Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

Recruiting now · Phase 3

Conditions studied: Acute Ischemic Stroke, Atrial Fibrillation

In brief

This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.

Key facts

Study ID

NCT05293080

Run by

Universitätsklinikum Hamburg-Eppendorf

People needed

1746

Starts

2025-11-06

Expected to finish

2031-09-01

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acute ischemic stroke in the previous four weeks, diagnosed by imaging (CT or MRI) or clinical diagnosis
• Possibility to start the trial treatment within 4 weeks after stroke, and as soon as clinically justifiable
• AF first detected ≤1 year prior to randomization
• Informed consent

You may not qualify if…

• End-stage cancer or life-expectancy < 12 months due to other advanced co-morbid illness
• Prior AF ablation or surgical therapy of AF
• Patients not suitable for rhythm control of AF due to cardiac conditions

Where it is running

• University Medical Center Hamburg-Eppendorf — Hamburg, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.